DONEPEZIL HYDROCHLORIDE
NDC 68180-527, DONEPEZIL HYDROCHLORIDE, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-527
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202782
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-527 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DONEPEZIL HYDROCHLORIDE23 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-527-06 | 68180052706 | 30 TABLET in 1 BOTTLE (68180-527-06) |
| 68180-527-09 | 68180052709 | 90 TABLET in 1 BOTTLE (68180-527-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/03e26183-3e07-45e8-a414-a8bad32483e2
Use it
Look up 68180-527 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-527 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-527. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.